This HTML5 document contains 59 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q62105042
rdf:type
wikibase:Item
schema:description
ensayu clínicu clinical trial клінічне випробування klinisch onderzoek կլինիկական փորձարկում
rdfs:label
Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
skos:prefLabel
Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
schema:name
Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
p:P1476
wds:Q62105042-14A451BC-B822-4226-89BB-AAD43BC98809
wdt:P1476
Phase II Trial of Bevacizumab, Gemcitabine, Oxaliplatin in Patients With Metastatic Pancreatic Adenocarcinoma
p:P582
wds:Q62105042-687D0FBF-32EE-419E-BB26-0EF6585B7581
wdt:P582
2006-08-01T00:00:00Z
p:P31
wds:Q62105042-59B97584-938F-4F1B-B1C9-B7E426E1F6FB
wdt:P31
wd:Q30612
p:P580
wds:Q62105042-04EED790-C28F-4170-B570-E998611EB074
wdt:P580
2005-06-01T00:00:00Z
p:P17
wds:Q62105042-27B4A95B-A5AC-4721-AD60-F9FFA0983FA6
wdt:P17
wd:Q30
p:P6153
wds:Q62105042-38CDE26F-6031-4A8E-9BE4-E5F1020229BF wds:Q62105042-54390555-5A57-4F68-ADFB-4F9E443BB25B wds:Q62105042-6C9D26AF-96C8-48F0-92F2-4BE33A88B7FA wds:Q62105042-76FB0F0F-BA1D-4368-9BF1-44D399578D91 wds:Q62105042-7B82978A-1723-4C1A-A113-F1FDD6C81CDF wds:Q62105042-9B8FCF4C-FCA0-44CA-B50B-0A7810218D35 wds:Q62105042-0CC613ED-955B-4942-8DDC-6A3493D1046B wds:Q62105042-A51EB9BD-4576-499A-BE1D-3F14671DDE78 wds:Q62105042-AC8EEC41-F8F9-4881-BFE8-11339DB0DA71 wds:Q62105042-BD579276-F766-47D8-96B1-D28EAE7C3F68 wds:Q62105042-194B92AC-8C9C-44D7-8522-F30DAB90F82B
wdt:P6153
wd:Q30269666 wd:Q30281210 wd:Q14716149 wd:Q30280192 wd:Q4731305 wd:Q3145247 wd:Q30280592 wd:Q30269543 wd:Q30270451 wd:Q30269547 wd:Q7654755
p:P4844
wds:Q62105042-D088FD7C-7797-4225-A554-CD8FCB952045 wds:Q62105042-ABDADDBF-0530-4BF2-908F-D5195CC9A81B wds:Q62105042-32CC7E79-3094-4DE2-9733-E77D2AA619E9
wdt:P4844
wd:Q414143 wd:Q413299 wd:Q422327
p:P859
wds:Q62105042-F7392AE1-8055-4E9D-8110-DFACEE9242B0
wdt:P859
wd:Q4732351
p:P1132
wds:Q62105042-80148788-FDB2-4974-B1D6-2C6C0DF50F96
wdt:P1132
53
p:P8363
wds:Q62105042-59F922FE-745A-4575-8142-287493A32F50
wdt:P8363
wd:Q78089383
p:P3098
wds:Q62105042-73FC1E8F-476F-49A2-ACEE-76DA36235884
wdt:P3098
NCT00112528
p:P6099
wds:Q62105042-3B66EC18-D027-49AF-B3CE-37FA545CAE64
wdt:P6099
wd:Q42824440
p:P8005
wds:Q62105042-5EB99876-BC43-4130-AD28-29A683B8DA27
wdt:P8005
wd:Q76651189